“Host Matters”! Improving high risk patient management Satellite symposium Milano Biofilm Meeting, 19 June 2015, 2.30 p.m. “The more we study the problem of chronic and recurrent infections and particularly that of biofilm-related infections, the more we understand that the host type plays a pivotal role both asbto concern the susceptibility to infection and the possibility to heal, if infected.” Prof. Dr. C. L. Romanò www.heraeus-medical.com Join the discussion on the options available for effective prevention and treatment of prosthetic joint infections in patients atbhigh risk of developing a post-surgical infection. An interdisciplinary faculty of experts in fields of septic surgery, infectious diseases, and antimicrobial biomaterials will update and advance the knowledge around the following questions. 1. Who are patients at high risk and what are the challenges? 2. What are possible implications for prophylaxis and treatment algorithms in high risk patients? 3. What are the limits of systemic prophylaxis in challenging patients and which solutions do exist to improve antibiotic use? 4. What is the role of antibiotic loaded bone cements? What are the differences between cements? Interdisciplinary experts forum C. L. Romanò Host matters! The high risk patient and the role of infection risk factors A. Soriano Forty years of standard antibiotic prophylaxis: should we go a step forward? H. Bösebeck Antibiotic loaded bone cements: choosing the right one! Chairs Prof. Dr. Carlo L. Romanò, Istituto Ortopedico Galeazzi IRCCS, Milano, Italy Dr. Alex Soriano, Hospital Clínic, Bone & Joint Infection Unit, Barcelona, Spain Dr. Hans Bösebeck, Heraeus Medical GmbH, Wehrheim, Germany www.heraeus-medical.com Heraeus Medical GmbH Philipp-Reis-Str. 8/13 61273 Wehrheim Germany
© Copyright 2024